Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors

NAEnrolling by invitationINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 5, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Inflammation BiomarkersInflammation
Interventions
BIOLOGICAL

endotoxin escherichia coli (E. coli) lipopolysaccharide (LPS)

Intravenous administration of endotoxin (0.8 ng/kg body weight)

OTHER

Placcebo

Placebo injection of 0.9% NaCl

Trial Locations (1)

Unknown

Department of emergency medicine, Linköping University Hospital, Region Östergötland, Linköping

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Stockholm University

OTHER

lead

University Hospital, Linkoeping

OTHER